Chronic heart failure: Outpatient management;Insuffisance cardiaque chronique: Prise en charge en milieu ambulatoire

Medecine et Hygiene

Volumn 58, Issue 2304, 2000, Pages 1292-1301

  Trindade, P Trigo ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; NEUROHORMONE; VASODILATOR AGENT;

CLINICAL TRIAL; HEART FAILURE; HUMAN; MORTALITY; OUTPATIENT CARE; PREVALENCE; PROGNOSIS; REVIEW;

EID: 0034616657     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Cohn JN. Prognostic factors in heart failure: Poverty amidst a wealth of variables. J Am Coll Cardiol 1989; 14; 571-2.
2. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993: 22 (Suppl. 4 A) 6A-13A.
3. The Task Force on Heart Failre of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-51.
4. Report of the American college of cardiology/American heart association task force on practice guidelines. Guidelines for the evaluation and management of heart failure. Circulation 1995; 92: 2764-84.
5. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-10.
6. Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the cooperative north scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
7. The SOLVD Invetigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293-302.
8. The SOLVD Investigators. Effect of enalapril on moratality and the developmernt of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med J 1991; 327: 685-91.
9. Elite II investigators. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomized trial - the Losartan Heart Failure Survival Study ELITE II. Lancet 2000; 355: 1582-7.
10. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure, Results of a veterans administration cooperative study (V-HeFT). N Engl J Med 1986; 314; 1547-52.
11. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-17.
12. Waagstein F, Bristone MR, Swedberg-Camerine F, et al. Benefecial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1441-6.
13. Packer M, Bristone, MR, Cohn JN, et al. The of carvedilol on morbiality and mortality in patients with chronic heart failure. N Engl Med 1996; 334: 1349-55.
14. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial, Lancet 1999; 353: 9-13.
15. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol cr/xl randomised intervention trial in congestive heart failure. Lancet 1999; 353: 2001-7.
16. The Digitals Investigation group. The effect of dagoxin on mortality and morbidity in patients with failure. N Engl J Med 1997; 336: 525-33.
17. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-14.
18. Singh SN, FLetcher RD, Gross Fischer S, et al. Amiodarone in patients with congestive heart failure and symptomatic ventricular arrythmia. N Engl J Med 1995; 333: 77-82.
19. Doval HC, Nul DR, O'Grancelli HO, Perrone SV, Bortman GR, Curiel R, for Grupo de Estudio de la brevida en la Insufiencia Cardiaca en Argetina (GESICA). Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-8.
20. Rickenbacher PR, Trindade PT, Haywood GA, et al. Tranplant candidates with severe left ventricular dysfunction managed with medical treatment: Charateristics and survival. J Am Coll Cardiol 1996; 27: 1192-7.